Trial
NCT02668783
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
—
Condition
Moderate to Severe Primary Dysmenorrhea
Intervention
Etonogestrel (ENG) 125 μg + 17β-estradiol (E2) 300 μg vaginal ring
Why stopped
Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-28